|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:HS2ST1-SH3GLB1 (FusionGDB2 ID:37593) |
Fusion Gene Summary for HS2ST1-SH3GLB1 |
Fusion gene summary |
Fusion gene information | Fusion gene name: HS2ST1-SH3GLB1 | Fusion gene ID: 37593 | Hgene | Tgene | Gene symbol | HS2ST1 | SH3GLB1 | Gene ID | 9653 | 51100 |
Gene name | heparan sulfate 2-O-sulfotransferase 1 | SH3 domain containing GRB2 like, endophilin B1 | |
Synonyms | dJ604K5.2 | Bif-1|CGI-61|PPP1R70|dJ612B15.2 | |
Cytomap | 1p22.3 | 1p22.3 | |
Type of gene | protein-coding | protein-coding | |
Description | heparan sulfate 2-O-sulfotransferase 12-O-sulfotransferase2OST | endophilin-B1Bax-interacting factor 1SH3 domain-containing GRB2-like protein B1SH3-containing protein SH3GLB1SH3-domain GRB2 like endophilin B1protein phosphatase 1, regulatory subunit 70testicular tissue protein Li 172 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q7LGA3 | . | |
Ensembl transtripts involved in fusion gene | ENST00000370550, ENST00000370551, ENST00000356813, | ENST00000482504, ENST00000535010, ENST00000370558, | |
Fusion gene scores | * DoF score | 11 X 5 X 7=385 | 4 X 4 X 3=48 |
# samples | 12 | 4 | |
** MAII score | log2(12/385*10)=-1.68182403997375 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: HS2ST1 [Title/Abstract] AND SH3GLB1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | HS2ST1(87380843)-SH3GLB1(87185190), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | SH3GLB1 | GO:0031334 | positive regulation of protein complex assembly | 19074440 |
Fusion gene breakpoints across HS2ST1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across SH3GLB1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LIHC | TCGA-DD-AAEG-01A | HS2ST1 | chr1 | 87380843 | - | SH3GLB1 | chr1 | 87185190 | + |
ChimerDB4 | LIHC | TCGA-DD-AAEG-01A | HS2ST1 | chr1 | 87380843 | + | SH3GLB1 | chr1 | 87185190 | + |
ChimerDB4 | LIHC | TCGA-DD-AAEG | HS2ST1 | chr1 | 87380843 | + | SH3GLB1 | chr1 | 87185190 | + |
Top |
Fusion Gene ORF analysis for HS2ST1-SH3GLB1 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000370550 | ENST00000482504 | HS2ST1 | chr1 | 87380843 | + | SH3GLB1 | chr1 | 87185190 | + |
5CDS-5UTR | ENST00000370550 | ENST00000535010 | HS2ST1 | chr1 | 87380843 | + | SH3GLB1 | chr1 | 87185190 | + |
5CDS-5UTR | ENST00000370551 | ENST00000482504 | HS2ST1 | chr1 | 87380843 | + | SH3GLB1 | chr1 | 87185190 | + |
5CDS-5UTR | ENST00000370551 | ENST00000535010 | HS2ST1 | chr1 | 87380843 | + | SH3GLB1 | chr1 | 87185190 | + |
In-frame | ENST00000370550 | ENST00000370558 | HS2ST1 | chr1 | 87380843 | + | SH3GLB1 | chr1 | 87185190 | + |
In-frame | ENST00000370551 | ENST00000370558 | HS2ST1 | chr1 | 87380843 | + | SH3GLB1 | chr1 | 87185190 | + |
intron-3CDS | ENST00000356813 | ENST00000370558 | HS2ST1 | chr1 | 87380843 | + | SH3GLB1 | chr1 | 87185190 | + |
intron-5UTR | ENST00000356813 | ENST00000482504 | HS2ST1 | chr1 | 87380843 | + | SH3GLB1 | chr1 | 87185190 | + |
intron-5UTR | ENST00000356813 | ENST00000535010 | HS2ST1 | chr1 | 87380843 | + | SH3GLB1 | chr1 | 87185190 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000370551 | HS2ST1 | chr1 | 87380843 | + | ENST00000370558 | SH3GLB1 | chr1 | 87185190 | + | 6346 | 513 | 389 | 1396 | 335 |
ENST00000370550 | HS2ST1 | chr1 | 87380843 | + | ENST00000370558 | SH3GLB1 | chr1 | 87185190 | + | 6320 | 487 | 363 | 1370 | 335 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000370551 | ENST00000370558 | HS2ST1 | chr1 | 87380843 | + | SH3GLB1 | chr1 | 87185190 | + | 0.00025037 | 0.9997496 |
ENST00000370550 | ENST00000370558 | HS2ST1 | chr1 | 87380843 | + | SH3GLB1 | chr1 | 87185190 | + | 0.000248892 | 0.99975115 |
Top |
Fusion Genomic Features for HS2ST1-SH3GLB1 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
HS2ST1 | chr1 | 87380843 | + | SH3GLB1 | chr1 | 87185189 | + | 9.19E-08 | 0.9999999 |
HS2ST1 | chr1 | 87380843 | + | SH3GLB1 | chr1 | 87185189 | + | 9.19E-08 | 0.9999999 |
HS2ST1 | chr1 | 87380843 | + | SH3GLB1 | chr1 | 87185189 | + | 9.19E-08 | 0.9999999 |
HS2ST1 | chr1 | 87380843 | + | SH3GLB1 | chr1 | 87185189 | + | 9.19E-08 | 0.9999999 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for HS2ST1-SH3GLB1 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:87380843/chr1:87185190) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
HS2ST1 | . |
FUNCTION: Catalyzes the transfer of sulfate to the C2-position of selected hexuronic acid residues within the maturing heparan sulfate (HS). 2-O-sulfation within HS, particularly of iduronate residues, is essential for HS to participate in a variety of high-affinity ligand-binding interactions and signaling processes. Mediates 2-O-sulfation of both L-iduronyl and D-glucuronyl residues (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | HS2ST1 | chr1:87380843 | chr1:87185190 | ENST00000370550 | + | 1 | 7 | 1_11 | 41 | 357.0 | Topological domain | Cytoplasmic |
Hgene | HS2ST1 | chr1:87380843 | chr1:87185190 | ENST00000370551 | + | 1 | 5 | 1_11 | 41 | 230.0 | Topological domain | Cytoplasmic |
Hgene | HS2ST1 | chr1:87380843 | chr1:87185190 | ENST00000370550 | + | 1 | 7 | 12_28 | 41 | 357.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
Hgene | HS2ST1 | chr1:87380843 | chr1:87185190 | ENST00000370551 | + | 1 | 5 | 12_28 | 41 | 230.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
Tgene | SH3GLB1 | chr1:87380843 | chr1:87185190 | ENST00000370558 | 1 | 9 | 155_195 | 71 | 366.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | SH3GLB1 | chr1:87380843 | chr1:87185190 | ENST00000482504 | 1 | 11 | 155_195 | 71 | 387.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | SH3GLB1 | chr1:87380843 | chr1:87185190 | ENST00000535010 | 0 | 8 | 155_195 | 0 | 266.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | SH3GLB1 | chr1:87380843 | chr1:87185190 | ENST00000370558 | 1 | 9 | 305_365 | 71 | 366.0 | Domain | SH3 | |
Tgene | SH3GLB1 | chr1:87380843 | chr1:87185190 | ENST00000482504 | 1 | 11 | 305_365 | 71 | 387.0 | Domain | SH3 | |
Tgene | SH3GLB1 | chr1:87380843 | chr1:87185190 | ENST00000535010 | 0 | 8 | 27_261 | 0 | 266.0 | Domain | BAR | |
Tgene | SH3GLB1 | chr1:87380843 | chr1:87185190 | ENST00000535010 | 0 | 8 | 305_365 | 0 | 266.0 | Domain | SH3 | |
Tgene | SH3GLB1 | chr1:87380843 | chr1:87185190 | ENST00000535010 | 0 | 8 | 1_30 | 0 | 266.0 | Region | Note=Membrane-binding amphipathic helix | |
Tgene | SH3GLB1 | chr1:87380843 | chr1:87185190 | ENST00000535010 | 0 | 8 | 1_37 | 0 | 266.0 | Region | Required for membrane binding |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | HS2ST1 | chr1:87380843 | chr1:87185190 | ENST00000370550 | + | 1 | 7 | 29_356 | 41 | 357.0 | Topological domain | Lumenal |
Hgene | HS2ST1 | chr1:87380843 | chr1:87185190 | ENST00000370551 | + | 1 | 5 | 29_356 | 41 | 230.0 | Topological domain | Lumenal |
Tgene | SH3GLB1 | chr1:87380843 | chr1:87185190 | ENST00000370558 | 1 | 9 | 27_261 | 71 | 366.0 | Domain | BAR | |
Tgene | SH3GLB1 | chr1:87380843 | chr1:87185190 | ENST00000482504 | 1 | 11 | 27_261 | 71 | 387.0 | Domain | BAR | |
Tgene | SH3GLB1 | chr1:87380843 | chr1:87185190 | ENST00000370558 | 1 | 9 | 1_30 | 71 | 366.0 | Region | Note=Membrane-binding amphipathic helix | |
Tgene | SH3GLB1 | chr1:87380843 | chr1:87185190 | ENST00000370558 | 1 | 9 | 1_37 | 71 | 366.0 | Region | Required for membrane binding | |
Tgene | SH3GLB1 | chr1:87380843 | chr1:87185190 | ENST00000482504 | 1 | 11 | 1_30 | 71 | 387.0 | Region | Note=Membrane-binding amphipathic helix | |
Tgene | SH3GLB1 | chr1:87380843 | chr1:87185190 | ENST00000482504 | 1 | 11 | 1_37 | 71 | 387.0 | Region | Required for membrane binding |
Top |
Fusion Gene Sequence for HS2ST1-SH3GLB1 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>37593_37593_1_HS2ST1-SH3GLB1_HS2ST1_chr1_87380843_ENST00000370550_SH3GLB1_chr1_87185190_ENST00000370558_length(transcript)=6320nt_BP=487nt AAAGGAGGGAGGGAAGGAAGGAAGAGAGGGAGGCGGGCAAGCAGGCGGGCGCGGGGGTCGGGGACTGAGGCAGTAGAGGGAGGCGAGAGC CCGGCAGCCGCTTCGCGCTGTTTGCTGCGCGGGCTTTTGGAGGGGGCGGCCGTTTAGTCGGCTGAGGAGAAGCGGACACCAGCGGCGTTG GTGATAGCGCCTGGGGGAGGGGGACTGGAGAGGCGAGAAGGGGGGTCGCTGCGGTGGTTCTCTCGCTGTCGCTCTCTCTTTGCCTCGCTC CCGGCTCGGCGGGCTCCTCCCGGCGTCTCTCTCGCCTCCGGGGTCCCGCTCCCCGCCCCCCGCGGTATGTCTTGATCCCGAGCAGCGGGT TTCATGGGGCTCCTCAGGATTATGATGCCGCCCAAGTTGCAGCTGCTGGCGGTGGTGGCCTTCGCGGTGGCGATGCTCTTCTTGGAAAAC CAGATCCAGAAACTGGAGGAGTCCCGCTCGAAGCTAGATGCCAGGATAGAAGAATTTGTTTATGAGAAACTGGATAGAAAAGCTCCAAGT CGTATAAACAACCCAGAACTTTTGGGACAATATATGATTGATGCAGGGACTGAGTTTGGCCCAGGAACAGCTTATGGTAATGCCCTTATT AAATGTGGAGAAACCCAAAAAAGAATTGGAACAGCAGACAGAGAACTGATTCAAACGTCAGCCTTAAATTTTCTTACTCCTTTAAGAAAC TTTATAGAAGGAGATTACAAAACAATTGCTAAAGAAAGGAAACTATTGCAAAATAAGAGACTGGATTTGGATGCTGCAAAAACGAGACTA AAAAAGGCAAAAGCTGCAGAAACTAGAAATTCATCTGAACAGGAATTAAGAATAACTCAAAGTGAATTTGATCGTCAAGCAGAGATTACC AGACTTCTGCTAGAGGGAATCAGCAGTACACATGCCCATCACCTTCGCTGTCTGAATGACTTTGTAGAAGCCCAGATGACTTACTATGCA CAGTGTTACCAGTATATGTTGGACCTCCAGAAACAACTGGGAAGTTTTCCATCCAATTATCTTAGTAACAACAATCAGACTTCTGTGACA CCTGTACCATCAGTTTTACCAAATGCGATTGGTTCTTCTGCCATGGCTTCAACAAGTGGCCTAGTAATCACCTCTCCTTCCAACCTCAGT GACCTTAAGGAGTGTAGTGGCAGCAGAAAGGCCAGGGTTCTCTATGATTATGATGCAGCAAACAGTACTGAATTATCACTTCTGGCAGAT GAGGTGATCACTGTGTTCAGTGTTGTTGGAATGGATTCAGACTGGCTAATGGGGGAAAGGGGAAACCAGAAGGGCAAGGTGCCAATTACC TACTTAGAACTGCTCAATTAAGTAGGTGGACTATGGAAAGGTTGCCCATCATGACTTTGTATTTATATACAATTAACTCTAAATAAAGCA GGTTAAGTATCTTCCATGTTAATGTGTTAAGAGACTGAAAATACCAGCCATCAGAAACTGGCCTTTCTGCCAATAAAGTTGCATGGTAAA TATTTCATTACAGAATTTATGTTAGAGCTTTCATGCCAAGAATGTTTTCTTACAAAATTCTCTTTTTATTGAGGTTTCACTAATAAGCAG CTTCTACTTTTGAGCCTCAACTTAAAGCAGAACTGTTTTCTACTGGATTTTTCATTAACAGCAAGCTTTTTCTTTTATGTAAAATAAATC TATTGTGAATTGATATCAGCGACTCATTTATTAGGTATAAATAATAGCCAAAGAATAAAATTAAAATTTATTTTAAACTTTCGGTCTTAA AAAGAGCTGTAGGATATAAACCTCTTTTGTGAAAAGTAGAATTTTCTGAATGCTTTCATAGACAAAAACGCATTTAAACTATGTTTACCT GGTTTTCCAACAGAAATCAAATGATTTTAATATTATGTTTTGATGGGTTATTTTCAGAGTTGTTTGGTTTTTTAAACACTACTGAATGGT TTCTTTTAAATTTAAGAACAACTAGTTCTTGAAAAGCAATACCGTATTTCTCTGATAAATTTGTAGTTAAGGTTCTAGAAAATCTAGGAC AAATTTACTTCATTAAACATAAAGTTTTTAAGATTATTCAGTTGGCACAATTTAATGCATAATTGGGATTGGATCCATTTACTGTACTGT GGTACAGTAAAGAGAATGTGTTCTTATTGAACAGCAGATTTGTATACAAATACGGAATAATGCAACTACATTATAAATTGTATACGAACA AAATAAATTGGGTCACTCTGAGCTTACTATTAAAACATTGAAAATTTATTAATGAACACAGGCTATCTTGATGAGGATCTCTGCTTATGA AACACATACTAATGAAATTATTAGTGACACATTGGAAGCTAGAAAATTGCTGTTGGGGCCATTGCTATAAATCATTGTTTCCATGTTAAG ACTTCTGTTCTAATTCATTCATTCAACAAACATTTGTTGAGGGCCAGATACTGTGCTGGTCAACTGGGGATACTGTCCTGAACAATATGC ACACAGTTCTTGCCCCTGCAGAGCTTAAAGACCATTAAAGGATACAGAAAATTAAGCAATTATCCTATAGTAGGATTCGTGGTGTGATGG GGAAAATACAAGGTACTGTATTTGGGAGTCATGTAACTCCAGTTTTGGGAGTGAGAGAGGGTCTGGGGAAGAACTGTTCCAGATAAAAAG ATGTGTAACCAAGATAGCATAGCACATTCTGACAACTAAAGCAATTTACTCTAACTTAAGCATGAAGTACAAAAGTATAGTTCATTTATT GAGGGAATGTTAAGCTATTAAAATGATACTTTTTGGTACTTTTAAAAAAATGAATACTTAAACACCGTTTTAAAATTTTGTGTTAAGAGC TCCTAATAAGAACTTGGTAAACATGTTGACAATTTAACTCACAGTCTAAACTTTAAAAGTAGTAGTTACCCTTTTATTTCTGTGCCATGA GACAAATTCTTCTGCAGTTTTATAGTTGTACAAGATGTTTTGACTCACTCTCAATTGCCATATTCTTAAAGAAACCCTGAAAAGCTGCTC AAGCTGGTCAGTTTTCTGTAAAACCAAGTAAATGAAATTTTCTCTCCCCTCAGAAAGGAAGTTCTACAGCCTAGAGTACCATCTATTGTG TTTTATAAGTCCAGATTTAGGCTTTGAAAGATCATACCAAAACTTCAGATCGACTTAAACAGCAACTATGAATTAGGTTTATGGGAAATG TAGTAATACAGGGGAAAGAATATCGGTAATGGAGTGAAATGGTCCTGGGTTCAAATCCAGTCTTCCTCACATATTGTGCTCTTTAAGCTT CAAATGAGATGTATAACTGCCTTTTCCTTACCAGTAAAATGAGGACAATAATTATGACACCATAGGGTGGTTGTGAGGATTAGCAAATGT TATCTTGTATTTCAGGTGCCTTTCAGGGAAAGGCTTGGCACATAGTAAACACATCCTGTAAATATCAGTTTCCCCTTGTTAGCCCCTGTA GCATCCTGACCTACCAAGTCTATAGGCCTTGCATATCACTGTGCACCAGAGATACCTCTTTTACATCTGGGCTCTGTTTTCTCTCTATCA ATCCTATCCTCCACCCTCTTTAAATCAGACCCCAGGTTTAACCTTCCCACAGTCAGTATAAATCATTTTTCAGAACTTTCAGCTTTCCAT CAAGTGAAAGTTGATTTTAGTTACCCAGTAATGTACAGAAACCTTCAATAATGTTAAGCTTCAAAGGCTTCTGGTACGTTTGTCTACCAC AGAACCACCACAATATATATGCTTGTTCTTAGGTTTATTGCTTTTTATTTTAATGGGGTTTGGTTGTTTGGGTTTTATTTTGGTTTTGGC TTATTTTAAAGTCAAGTTTAGTTTTTACTCAGGTAAAGGCCTGAAGTTTCTTGGGCGTGGAAGAAAAAGCTTGGGAAGCCTATTAATTCA TGGTGCAGTTCAGAATTGTTTAAATAAGCTCTGTGCCACTGAGCTTAATCTGAAAGTATAGTGACATGTGAAGGATGCACATATGAATGA AAAACTAAAATAATTGTAGGCTCTTCTATAAATGAAAAAAAAAGTGATTGGATTGTGTCTACCTTTTTCCTCAAAGTAATCTAACCTAAA CGGTCATGGTGTTAAAACTTTTTATGGTGCTAATCAGAAAAATTGATGTTGCAAGAAATGAGGTCTCAAAAATGGGAATGTGCCTCCTCA CTCTGCGTCACATGGGAAATAAATCCTGAGGCCAGGATCACCAGTGGGGTAGAGTCATCTTCATAGTCTCCTGTTATCCTCCCCCTGAAC AAAGAACAAAGTGAGACTGGGAAGCTAGTGTTGGGGAAACATTTCTGGGATAAACTGTGGAGTGGAGAAGACAATGGAGGGCAAGGCAAA AACCCACAGACTTGTTTACCCATAGAGGCCCCACTCACCTCCATGCTGACAGAATTCCAGAAAAATTCCTTCCCTATCTCCCAAACACCT GAAATTCTGAAATATTGCCCTACTATTTAGCACTTTAAGCTTCAGTGAGGTGCTGTAATGGAGAGATAGCTTCATAGTTTAGCCTATAGC CAACTTTGCCTCAAGACCTCCAGATAAGATGAAGTGGCTTTTACCTCATGTGAGTCTCAAACGCTGGAGAGAGAGTTCCACAACCACCCC TGCCCTTTCTCCCATATTACGCTCATTAGAAAGTCTACTCAGGGCTGGGTGCCGTGGCTCATGCCTGTAATCCCAGCACTTTGGAGGCTG AGGCGGGTGGATCATCTGAGGTCAGGAGTTCGAGACCAGCCTGGCCAACATGGGGAAACCCTGTCTCTACTGAAAATATAAAAATTAGCC GGGCATGGTGGCGTGCACCTGTAATTCCAGCTACTCGGGAGGCTGAGGCAGGAGAATCACTTGAACCCCAGAGGCAGAGGCTACAGTGAG CCAAGATTGCACCACTGCACTCCAACCTGGGTGATAGAATAAGACTCTTGTCTCAAGGAAAGAAAAAATGTCTACTCAGTAGAGCAGTGA TTGGCAAAGTGTGAGACCCCAGACCGGCAATATTGGCATCTCCTGGAGACTTGTTTAAAATGCTGATTACTATTTTCAAGAACTTTCTAC CTTCATTTTTACTTATTTTTTGTTTTCAAGGGCTCATGGAATCAGTCTTCCATGTGACAGCTTTTTAAATATTTTAAGACAAAAACTGAG TCTTCTAATCTTAATTGTGTTCTAGCAGTAGTCATTGTAATTATAGTTATTTTTATAATTTATTTGTTTAGTGTATATCTGTCACTCTAG AATGTAGGCTCCCTGAGATAAAAACTATAATTCTTTTGATGGCAGTTACATTCCCAACTCTTAGCACAAGATCTAGGACATAGTATGAAC TCAATAAATTTTTGTTGAATGAAAGAAAAATGCAAATTTATAAGCCTTTTCAGAGACCTACTGAATCAAACTCTGAGAGTGGAGCCCAGC AATCTGTTGTAAAAGCTGTTTGAGTAATACTGTTGCACTCTAAGCTTGAGAACCACTGCAATAGAACTAAGAGAACATTCATTTCACCTT CAGGCCTATTCTCTGACATCACTTGAAAAATCCTCTCTGCCTTCTGTAACCCTTAACCAACAACAGTGCCCTGTCCATGTAGGGGAAACT TCTGGGCTGTATTACAAGTGGGTAGGAAGGTATAAGGATATCATAGTGGGAAGTATTGCTTAGAATGCCAGTACTTGTTTGCTGTGGAAG GTTTCTAGGAATGGATTGCTTAGTCTAAAGTAAGCACTACCACCATCCACGTTTTCACTCAACACAGTGCCTTTTAATTGGTGACTAACA TCAAAACACCTTGACAAACCGTTAAAACAGTATCAGAAACCATGTGTACATCCCTGTGCCTCTTAGATTGCTAAGTTCTGCTCTCATTCT TACTTCAAAGGACACTTTTTAAAGAATTGTTAATGCTTTTTTATAATACAAGTCATAGCCCTGTTGGCAAAAAGAAAAAAGATTCAGTGA GAAAGAAAAATCACTGATAATTCCATCATCCAGGGAGAACCACTGTTATTTAAGTATATGGCCTTCCAGACTTTTCTGTGCATTTATAGA TATTTTTAATGGGATCAAAGTGTACATACTGTTTTGTAACTTTTTTTCACTCAACAATACCATGACTGTCTTGCTGTGTCAAGTATATTT CTACATCTCTTAATGGCTGCATGATATTCCATCATATGTGCCACATTTTATTAAACTACTGTTCAATTTTTAGGTTTCCAACTTTCATTA >37593_37593_1_HS2ST1-SH3GLB1_HS2ST1_chr1_87380843_ENST00000370550_SH3GLB1_chr1_87185190_ENST00000370558_length(amino acids)=335AA_BP=33 MGLLRIMMPPKLQLLAVVAFAVAMLFLENQIQKLEESRSKLDARIEEFVYEKLDRKAPSRINNPELLGQYMIDAGTEFGPGTAYGNALIK CGETQKRIGTADRELIQTSALNFLTPLRNFIEGDYKTIAKERKLLQNKRLDLDAAKTRLKKAKAAETRNSSEQELRITQSEFDRQAEITR LLLEGISSTHAHHLRCLNDFVEAQMTYYAQCYQYMLDLQKQLGSFPSNYLSNNNQTSVTPVPSVLPNAIGSSAMASTSGLVITSPSNLSD -------------------------------------------------------------- >37593_37593_2_HS2ST1-SH3GLB1_HS2ST1_chr1_87380843_ENST00000370551_SH3GLB1_chr1_87185190_ENST00000370558_length(transcript)=6346nt_BP=513nt CGGTGGAGGGGCGCGCGGCCGCGAGCAAAGGAGGGAGGGAAGGAAGGAAGAGAGGGAGGCGGGCAAGCAGGCGGGCGCGGGGGTCGGGGA CTGAGGCAGTAGAGGGAGGCGAGAGCCCGGCAGCCGCTTCGCGCTGTTTGCTGCGCGGGCTTTTGGAGGGGGCGGCCGTTTAGTCGGCTG AGGAGAAGCGGACACCAGCGGCGTTGGTGATAGCGCCTGGGGGAGGGGGACTGGAGAGGCGAGAAGGGGGGTCGCTGCGGTGGTTCTCTC GCTGTCGCTCTCTCTTTGCCTCGCTCCCGGCTCGGCGGGCTCCTCCCGGCGTCTCTCTCGCCTCCGGGGTCCCGCTCCCCGCCCCCCGCG GTATGTCTTGATCCCGAGCAGCGGGTTTCATGGGGCTCCTCAGGATTATGATGCCGCCCAAGTTGCAGCTGCTGGCGGTGGTGGCCTTCG CGGTGGCGATGCTCTTCTTGGAAAACCAGATCCAGAAACTGGAGGAGTCCCGCTCGAAGCTAGATGCCAGGATAGAAGAATTTGTTTATG AGAAACTGGATAGAAAAGCTCCAAGTCGTATAAACAACCCAGAACTTTTGGGACAATATATGATTGATGCAGGGACTGAGTTTGGCCCAG GAACAGCTTATGGTAATGCCCTTATTAAATGTGGAGAAACCCAAAAAAGAATTGGAACAGCAGACAGAGAACTGATTCAAACGTCAGCCT TAAATTTTCTTACTCCTTTAAGAAACTTTATAGAAGGAGATTACAAAACAATTGCTAAAGAAAGGAAACTATTGCAAAATAAGAGACTGG ATTTGGATGCTGCAAAAACGAGACTAAAAAAGGCAAAAGCTGCAGAAACTAGAAATTCATCTGAACAGGAATTAAGAATAACTCAAAGTG AATTTGATCGTCAAGCAGAGATTACCAGACTTCTGCTAGAGGGAATCAGCAGTACACATGCCCATCACCTTCGCTGTCTGAATGACTTTG TAGAAGCCCAGATGACTTACTATGCACAGTGTTACCAGTATATGTTGGACCTCCAGAAACAACTGGGAAGTTTTCCATCCAATTATCTTA GTAACAACAATCAGACTTCTGTGACACCTGTACCATCAGTTTTACCAAATGCGATTGGTTCTTCTGCCATGGCTTCAACAAGTGGCCTAG TAATCACCTCTCCTTCCAACCTCAGTGACCTTAAGGAGTGTAGTGGCAGCAGAAAGGCCAGGGTTCTCTATGATTATGATGCAGCAAACA GTACTGAATTATCACTTCTGGCAGATGAGGTGATCACTGTGTTCAGTGTTGTTGGAATGGATTCAGACTGGCTAATGGGGGAAAGGGGAA ACCAGAAGGGCAAGGTGCCAATTACCTACTTAGAACTGCTCAATTAAGTAGGTGGACTATGGAAAGGTTGCCCATCATGACTTTGTATTT ATATACAATTAACTCTAAATAAAGCAGGTTAAGTATCTTCCATGTTAATGTGTTAAGAGACTGAAAATACCAGCCATCAGAAACTGGCCT TTCTGCCAATAAAGTTGCATGGTAAATATTTCATTACAGAATTTATGTTAGAGCTTTCATGCCAAGAATGTTTTCTTACAAAATTCTCTT TTTATTGAGGTTTCACTAATAAGCAGCTTCTACTTTTGAGCCTCAACTTAAAGCAGAACTGTTTTCTACTGGATTTTTCATTAACAGCAA GCTTTTTCTTTTATGTAAAATAAATCTATTGTGAATTGATATCAGCGACTCATTTATTAGGTATAAATAATAGCCAAAGAATAAAATTAA AATTTATTTTAAACTTTCGGTCTTAAAAAGAGCTGTAGGATATAAACCTCTTTTGTGAAAAGTAGAATTTTCTGAATGCTTTCATAGACA AAAACGCATTTAAACTATGTTTACCTGGTTTTCCAACAGAAATCAAATGATTTTAATATTATGTTTTGATGGGTTATTTTCAGAGTTGTT TGGTTTTTTAAACACTACTGAATGGTTTCTTTTAAATTTAAGAACAACTAGTTCTTGAAAAGCAATACCGTATTTCTCTGATAAATTTGT AGTTAAGGTTCTAGAAAATCTAGGACAAATTTACTTCATTAAACATAAAGTTTTTAAGATTATTCAGTTGGCACAATTTAATGCATAATT GGGATTGGATCCATTTACTGTACTGTGGTACAGTAAAGAGAATGTGTTCTTATTGAACAGCAGATTTGTATACAAATACGGAATAATGCA ACTACATTATAAATTGTATACGAACAAAATAAATTGGGTCACTCTGAGCTTACTATTAAAACATTGAAAATTTATTAATGAACACAGGCT ATCTTGATGAGGATCTCTGCTTATGAAACACATACTAATGAAATTATTAGTGACACATTGGAAGCTAGAAAATTGCTGTTGGGGCCATTG CTATAAATCATTGTTTCCATGTTAAGACTTCTGTTCTAATTCATTCATTCAACAAACATTTGTTGAGGGCCAGATACTGTGCTGGTCAAC TGGGGATACTGTCCTGAACAATATGCACACAGTTCTTGCCCCTGCAGAGCTTAAAGACCATTAAAGGATACAGAAAATTAAGCAATTATC CTATAGTAGGATTCGTGGTGTGATGGGGAAAATACAAGGTACTGTATTTGGGAGTCATGTAACTCCAGTTTTGGGAGTGAGAGAGGGTCT GGGGAAGAACTGTTCCAGATAAAAAGATGTGTAACCAAGATAGCATAGCACATTCTGACAACTAAAGCAATTTACTCTAACTTAAGCATG AAGTACAAAAGTATAGTTCATTTATTGAGGGAATGTTAAGCTATTAAAATGATACTTTTTGGTACTTTTAAAAAAATGAATACTTAAACA CCGTTTTAAAATTTTGTGTTAAGAGCTCCTAATAAGAACTTGGTAAACATGTTGACAATTTAACTCACAGTCTAAACTTTAAAAGTAGTA GTTACCCTTTTATTTCTGTGCCATGAGACAAATTCTTCTGCAGTTTTATAGTTGTACAAGATGTTTTGACTCACTCTCAATTGCCATATT CTTAAAGAAACCCTGAAAAGCTGCTCAAGCTGGTCAGTTTTCTGTAAAACCAAGTAAATGAAATTTTCTCTCCCCTCAGAAAGGAAGTTC TACAGCCTAGAGTACCATCTATTGTGTTTTATAAGTCCAGATTTAGGCTTTGAAAGATCATACCAAAACTTCAGATCGACTTAAACAGCA ACTATGAATTAGGTTTATGGGAAATGTAGTAATACAGGGGAAAGAATATCGGTAATGGAGTGAAATGGTCCTGGGTTCAAATCCAGTCTT CCTCACATATTGTGCTCTTTAAGCTTCAAATGAGATGTATAACTGCCTTTTCCTTACCAGTAAAATGAGGACAATAATTATGACACCATA GGGTGGTTGTGAGGATTAGCAAATGTTATCTTGTATTTCAGGTGCCTTTCAGGGAAAGGCTTGGCACATAGTAAACACATCCTGTAAATA TCAGTTTCCCCTTGTTAGCCCCTGTAGCATCCTGACCTACCAAGTCTATAGGCCTTGCATATCACTGTGCACCAGAGATACCTCTTTTAC ATCTGGGCTCTGTTTTCTCTCTATCAATCCTATCCTCCACCCTCTTTAAATCAGACCCCAGGTTTAACCTTCCCACAGTCAGTATAAATC ATTTTTCAGAACTTTCAGCTTTCCATCAAGTGAAAGTTGATTTTAGTTACCCAGTAATGTACAGAAACCTTCAATAATGTTAAGCTTCAA AGGCTTCTGGTACGTTTGTCTACCACAGAACCACCACAATATATATGCTTGTTCTTAGGTTTATTGCTTTTTATTTTAATGGGGTTTGGT TGTTTGGGTTTTATTTTGGTTTTGGCTTATTTTAAAGTCAAGTTTAGTTTTTACTCAGGTAAAGGCCTGAAGTTTCTTGGGCGTGGAAGA AAAAGCTTGGGAAGCCTATTAATTCATGGTGCAGTTCAGAATTGTTTAAATAAGCTCTGTGCCACTGAGCTTAATCTGAAAGTATAGTGA CATGTGAAGGATGCACATATGAATGAAAAACTAAAATAATTGTAGGCTCTTCTATAAATGAAAAAAAAAGTGATTGGATTGTGTCTACCT TTTTCCTCAAAGTAATCTAACCTAAACGGTCATGGTGTTAAAACTTTTTATGGTGCTAATCAGAAAAATTGATGTTGCAAGAAATGAGGT CTCAAAAATGGGAATGTGCCTCCTCACTCTGCGTCACATGGGAAATAAATCCTGAGGCCAGGATCACCAGTGGGGTAGAGTCATCTTCAT AGTCTCCTGTTATCCTCCCCCTGAACAAAGAACAAAGTGAGACTGGGAAGCTAGTGTTGGGGAAACATTTCTGGGATAAACTGTGGAGTG GAGAAGACAATGGAGGGCAAGGCAAAAACCCACAGACTTGTTTACCCATAGAGGCCCCACTCACCTCCATGCTGACAGAATTCCAGAAAA ATTCCTTCCCTATCTCCCAAACACCTGAAATTCTGAAATATTGCCCTACTATTTAGCACTTTAAGCTTCAGTGAGGTGCTGTAATGGAGA GATAGCTTCATAGTTTAGCCTATAGCCAACTTTGCCTCAAGACCTCCAGATAAGATGAAGTGGCTTTTACCTCATGTGAGTCTCAAACGC TGGAGAGAGAGTTCCACAACCACCCCTGCCCTTTCTCCCATATTACGCTCATTAGAAAGTCTACTCAGGGCTGGGTGCCGTGGCTCATGC CTGTAATCCCAGCACTTTGGAGGCTGAGGCGGGTGGATCATCTGAGGTCAGGAGTTCGAGACCAGCCTGGCCAACATGGGGAAACCCTGT CTCTACTGAAAATATAAAAATTAGCCGGGCATGGTGGCGTGCACCTGTAATTCCAGCTACTCGGGAGGCTGAGGCAGGAGAATCACTTGA ACCCCAGAGGCAGAGGCTACAGTGAGCCAAGATTGCACCACTGCACTCCAACCTGGGTGATAGAATAAGACTCTTGTCTCAAGGAAAGAA AAAATGTCTACTCAGTAGAGCAGTGATTGGCAAAGTGTGAGACCCCAGACCGGCAATATTGGCATCTCCTGGAGACTTGTTTAAAATGCT GATTACTATTTTCAAGAACTTTCTACCTTCATTTTTACTTATTTTTTGTTTTCAAGGGCTCATGGAATCAGTCTTCCATGTGACAGCTTT TTAAATATTTTAAGACAAAAACTGAGTCTTCTAATCTTAATTGTGTTCTAGCAGTAGTCATTGTAATTATAGTTATTTTTATAATTTATT TGTTTAGTGTATATCTGTCACTCTAGAATGTAGGCTCCCTGAGATAAAAACTATAATTCTTTTGATGGCAGTTACATTCCCAACTCTTAG CACAAGATCTAGGACATAGTATGAACTCAATAAATTTTTGTTGAATGAAAGAAAAATGCAAATTTATAAGCCTTTTCAGAGACCTACTGA ATCAAACTCTGAGAGTGGAGCCCAGCAATCTGTTGTAAAAGCTGTTTGAGTAATACTGTTGCACTCTAAGCTTGAGAACCACTGCAATAG AACTAAGAGAACATTCATTTCACCTTCAGGCCTATTCTCTGACATCACTTGAAAAATCCTCTCTGCCTTCTGTAACCCTTAACCAACAAC AGTGCCCTGTCCATGTAGGGGAAACTTCTGGGCTGTATTACAAGTGGGTAGGAAGGTATAAGGATATCATAGTGGGAAGTATTGCTTAGA ATGCCAGTACTTGTTTGCTGTGGAAGGTTTCTAGGAATGGATTGCTTAGTCTAAAGTAAGCACTACCACCATCCACGTTTTCACTCAACA CAGTGCCTTTTAATTGGTGACTAACATCAAAACACCTTGACAAACCGTTAAAACAGTATCAGAAACCATGTGTACATCCCTGTGCCTCTT AGATTGCTAAGTTCTGCTCTCATTCTTACTTCAAAGGACACTTTTTAAAGAATTGTTAATGCTTTTTTATAATACAAGTCATAGCCCTGT TGGCAAAAAGAAAAAAGATTCAGTGAGAAAGAAAAATCACTGATAATTCCATCATCCAGGGAGAACCACTGTTATTTAAGTATATGGCCT TCCAGACTTTTCTGTGCATTTATAGATATTTTTAATGGGATCAAAGTGTACATACTGTTTTGTAACTTTTTTTCACTCAACAATACCATG ACTGTCTTGCTGTGTCAAGTATATTTCTACATCTCTTAATGGCTGCATGATATTCCATCATATGTGCCACATTTTATTAAACTACTGTTC >37593_37593_2_HS2ST1-SH3GLB1_HS2ST1_chr1_87380843_ENST00000370551_SH3GLB1_chr1_87185190_ENST00000370558_length(amino acids)=335AA_BP=33 MGLLRIMMPPKLQLLAVVAFAVAMLFLENQIQKLEESRSKLDARIEEFVYEKLDRKAPSRINNPELLGQYMIDAGTEFGPGTAYGNALIK CGETQKRIGTADRELIQTSALNFLTPLRNFIEGDYKTIAKERKLLQNKRLDLDAAKTRLKKAKAAETRNSSEQELRITQSEFDRQAEITR LLLEGISSTHAHHLRCLNDFVEAQMTYYAQCYQYMLDLQKQLGSFPSNYLSNNNQTSVTPVPSVLPNAIGSSAMASTSGLVITSPSNLSD -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for HS2ST1-SH3GLB1 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for HS2ST1-SH3GLB1 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for HS2ST1-SH3GLB1 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |